A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate

C. Jesam, L. Cochon, A.M. Salvatierra, A. Williams, N. Kapp, D. Levy-Gompel, V. Brache

Open source

DOI
10.1016/j.contraception.2015.12.015
Published
2016-04
Container
Contraception
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.contraception.2015.12.015,
  title = {A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate},
  author = {C. Jesam and L. Cochon and A.M. Salvatierra and A. Williams and N. Kapp and D. Levy-Gompel and V. Brache},
  year = {2016},
  journal = {Contraception},
  doi = {10.1016/j.contraception.2015.12.015},
  url = {https://doi.org/10.1016/j.contraception.2015.12.015}
}

RIS

TY  - JOUR
TI  - A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate
AU  - C. Jesam
AU  - L. Cochon
AU  - A.M. Salvatierra
AU  - A. Williams
AU  - N. Kapp
AU  - D. Levy-Gompel
AU  - V. Brache
PY  - 2016
JO  - Contraception
DO  - 10.1016/j.contraception.2015.12.015
UR  - https://doi.org/10.1016/j.contraception.2015.12.015
ER  - 

APA

Jesam, C., Cochon, L., Salvatierra, A., Williams, A., Kapp, N., Levy-Gompel, D., & Brache, V. (2016). A prospective, open-label, multicenter study to assess the pharmacodynamics and safety of repeated use of 30 mg ulipristal acetate. Contraception. https://doi.org/10.1016/j.contraception.2015.12.015

Source records